FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE Drug Patent Profile
✉ Email this page to a colleague
When do Famotidine, Calcium Carbonate, And Magnesium Hydroxide patents expire, and what generic alternatives are available?
Famotidine, Calcium Carbonate, And Magnesium Hydroxide is a drug marketed by Perrigo R And D and is included in two NDAs.
The generic ingredient in FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE is calcium carbonate; famotidine; magnesium hydroxide. There are two hundred and eighty-two drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the calcium carbonate; famotidine; magnesium hydroxide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE?
- What are the global sales for FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE?
- What is Average Wholesale Price for FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE?
Summary for FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 18 |
DailyMed Link: | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE at DailyMed |
Pharmacology for FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE
US Patents and Regulatory Information for FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Perrigo R And D | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | calcium carbonate; famotidine; magnesium hydroxide | TABLET, CHEWABLE;ORAL | 077355-001 | Feb 6, 2008 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Perrigo R And D | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | calcium carbonate; famotidine; magnesium hydroxide | TABLET, CHEWABLE;ORAL | 204782-001 | Aug 29, 2016 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |